newsfilter
← Latest News
PR Newswire·

BiondVax to present at LD Micro Investor Conference in Los Angeles

JERUSALEM , Oct. 11, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) ("BiondVax"), a biotechnology company focused on developing, manufacturing, and commercializing innovative products for the